Contact Us Today|info@empharmd.com

About empharmd

Emergency medicine clinical pharmacist and clinical toxicologist

New articles and evidence updates

New articles and evidence updates Trying to stay up to date is tough. New articles and evidence updates don't just find you... right? Let's make staying up to date in the literature a whole lot easier. Who wants to search through journals and pubmed? Nobody. To tons of people, including myself, this task makes staying up to date a chore. What's worse is that it will turn some folks off entirely. How about turning the [...]

By |2019-11-16T16:27:10-05:00November 17th, 2019|Classic EM PharmD|0 Comments

FOAM for emergency medicine pharmacists

FOAM for emergency medicine pharmacists: PharmFOAM Don't waste time searching through updates to see what's new anymore. This is the best way to stay up to date in FOAM and be aware of the latest evidence based medicine updates. I call it PharmFOAM: FOAM for emergency medicine pharmacists. Here's what I'm reading and following today: That's it for PharmFOAM: FOAM for emergency medicine pharmacists! Make sure to click follow to keep up [...]

By |2019-11-16T15:37:07-05:00November 15th, 2019|Classic EM PharmD|0 Comments

Free Book Giveaway

The friendly folks at High-Yield MED Reviews were gracious enough to provide 20 free copies of two of my new eBooks. To get your FREE eBook, email me at iempharmd@gmail.com. But do it fast before all 20 are gone!

By |2019-10-26T12:06:35-05:00October 26th, 2019|EM PharmD Core|1 Comment

Diphacinone Toxicity

  Daniel Hu, PharmD, BCCCP Critical Care and Emergency Medicine Pharmacist Providence St. Peter Hospital Diphacinone (2-diphenylacetyl-1,3-indanedione, CAS Number 82-66-6) is an indandione-type anticoagulant.1,2 It falls into a class of compounds known as long-acting anticoagulant rodenticides, along with brodifacoum, bromadiolone, chlorophacinone, and difenacoum, which inhibit the synthesis of clotting factors II, VII, IX, and X. These compounds were developed to replace warfarin in rodenticides and many available mouse and rat baits today contain these superwarfarins.1 [...]

By |2019-11-16T15:38:05-05:00September 30th, 2019|EM PharmD Core|0 Comments

Cannabinoid Hyperemesis Syndrome (CHS): Getting “Into the Weeds” on a Complication of Chronic Marijuana Use

Guest post by Evan Mulvihill, PharmD on the hot topic of Cannabinoid Hyperemesis Syndrome

By |2019-07-19T08:09:38-05:00July 19th, 2019|Classic EM PharmD|0 Comments

“What is the INR of FFP?”

I frequently encounter people touting that "The INR of FFP is like 1.6 or something". Indeed I learned something similar myself at some point. It turns out however that the mean INR of FFP is actually 1.1 (Transfusion 2005;45:1234-5.). So why does it seem like no matter how much FFP you tend to give, it is very difficult to get the INR much lower than 1.6 or so?As can be seen from the image below [...]

By |2018-05-21T13:56:00-05:00May 21st, 2018|EM PharmD Blog|0 Comments